General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-10 | 2024-03 | 0 | -0.02 | N/A | N/A |
2024-03-05 | 2023-12 | 0 | -0.02 | N/A | N/A |
2023-11-09 | 2023-09 | 0 | -0.02 | N/A | N/A |
2023-08-09 | 2023-06 | 0 | -0.01 | N/A | N/A |
2023-05-10 | 2023-03 | 0 | -0.01 | N/A | N/A |
2023-02-28 | 2022-12 | 0 | -0.03 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2014-03-11 | Oppenheimer | Downgrade | Outperform | Perform |
2013-10-15 | Oppenheimer | Upgrade | Outperform | |
2013-09-18 | Summer Street Research | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2015-06-29 | COGNATE BIOSERVICES, INC. | Beneficial Owner (10% or more) | 18.46M | Sale |
2015-11-04 | WOODFORD INVESTMENT MANAGEMENT LLP | Beneficial Owner (10% or more) | 18.32M | Ownership Statement |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-09-29 | Woodford Investment Management LLP | 25.92M | 13.99M | 20.79% |
2016-09-29 | Credit Suisse/ | 1.90M | 1.03M | 1.52% |
2016-09-29 | Vanguard Group, Inc. (The) | 1.38M | 744.63K | 1.11% |
2016-09-29 | Goldman Sachs Group, Inc. | 994.70K | 537.14K | 0.80% |
2016-09-29 | BlackRock Institutional Trust Company, N.A. | 717.91K | 387.67K | 0.58% |
2016-09-29 | Millennium Management LLC | 357.41K | 193.00K | 0.29% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-06-29 | Vanguard Total Stock Market Index Fund | 968.77K | 561.89K | 0.78% |
2016-06-29 | Vanguard Extended Market Index Fund | 546.67K | 317.07K | 0.44% |
2016-08-30 | Fidelity Extended Market Index Fund | 158.54K | 53.90K | 0.13% |
2016-08-30 | Fidelity Total Market Index Fund | 60.54K | 20.58K | 0.05% |
2016-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 33.90K | 19.66K | 0.03% |
2016-08-30 | Fidelity NASDAQ Composite Index Fund | 27.00K | 9.18K | 0.02% |
Split | Date |
---|---|
0.0625 : 1 | 2012-09-26 |
0.06667 : 1 | 2007-06-28 |
Boy Evaluate Pharma sure must have been smoking something with that analysis
It’s because he published previous articles silly
If I was short I’d be nervous
Maybe Bosch dropped out due to bad data.
Morten is sitting on the beach and I’m sitting in a shithole mobile home with a portable heater and my landlord wants my lease renewed Feb 1. I need TLD so I can sell my 130k share and get the heat turned back on.
Stayed green? This Fu…..stock is down 50%!!!
People have to understand the situation at the FDA and what’s going on and their procedure for review. The FDA is prioritizing Covid drugs and shelving others slowing down the process. It’s a crap shoot that they will receive a timely review
Past tense
Yes they are running out of money. It’s a binary moment for them. It’s is a do or die thing and the risk/reward is high.
TLD will do little in the short run because it will hit 4-5$ on great TLD then roll back to 1.50 and the rush out the door by retail holders. That scenario will be the moral wound because they MUST do an offering immediately to survive. The only other king shot is a buyout and why pay top $ when Merck can buy it out of a BK sale. Am I wrong?
The next news should be a reverse split. I’d say unless we move back up to level 1 and and shrink the billion shares in the hands of retail we won’t survive. Merrill refused to sell me shares in my private client account.
The sad part is that currently the financial fate of the company is in the hands of day traders and unless LO does a reverse and leaves the OTC no serious institutional players will change this reality
The smart way to play NWBO is to not own it until the day after the good news that’s coming. The stock will gap on the open and retail will dump into the rally driving the stock to a price lower than it is right now. That is when you buy and hold as it recovers from the retrace.
50% out tomorrow if your smart
That spooks the F… out of me.
The last post tells the story. UNTIL!!
I’m just asking for why my logic isn’t correct. Does this look like a paid trolls acct?
If there isn’t a buyout the chances of them even surviving is not possible. The money needed to launch an effective production and sales team cost at least $ 100 million +
If your realistic on the news the absolute max would be $2 and that’s pushing it. I know a few years from now that could change but for now don’t be foolish. Tell me where I’m wrong.
Logic tells you it’s priced in with the current market cap.